The Pennant Group, Inc. (PNTG)
NASDAQ: PNTG · Real-Time Price · USD
26.08
-0.72 (-2.69%)
At close: Aug 13, 2025, 4:00 PM
26.56
+0.48 (1.84%)
After-hours: Aug 13, 2025, 5:37 PM EDT
The Pennant Group Market Cap
The Pennant Group has a market cap or net worth of $901.38 million as of August 13, 2025. Its market cap has decreased by -2.79% in one year.
Market Cap
901.38M
Enterprise Value
1.21B
1-Year Change
-2.79%
Ranking
Category
Stock Price
$26.08
Market Cap Chart
Since October 1, 2019, The Pennant Group's market cap has increased from $422.52M to $901.38M, an increase of 113.33%. That is a compound annual growth rate of 13.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 901.38M | -1.05% |
| Dec 31, 2024 | 910.92M | 118.67% |
| Dec 29, 2023 | 416.58M | 27.84% |
| Dec 30, 2022 | 325.85M | -50.42% |
| Dec 31, 2021 | 657.25M | -59.84% |
| Dec 31, 2020 | 1.64B | 77.73% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 1, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |